LAWRENCE, Mass., Feb. 24, 2014 /PRNewswire/ — NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, is proud to celebrate with former patient Laurie and her husband/care partner Mike two significant life milestones: their 30 year wedding anniversary and Laurie’s second kidney transplant. For the couple, more frequent home hemodialysis (HHD) with the NxStage® System One™ proved to be a good personal fit for them. The convenience and flexibility of the therapy not only helped them stay focused on their lifestyle, but also gave them the opportunity to focus their collective energy on finding a second kidney donor. Laurie and Mike vowed when they first married for better or for worse, in sickness and in health, and Mike has stuck by Laurie’s side with every step of her journey with kidney failure.
From the first day of Laurie’s diagnosis with end stage renal disease (ESRD), Mike aided Laurie through long recovery periods following in-center dialysis treatment, and after 20 years of marriage, he was finally able to donate his own kidney to better Laurie’s quality of life. Ten years later, Mike’s transplanted kidney ceased to function in Laurie’s body. Determined to find an alternative to an in-center dialysis plan, Mike and Laurie turned to more frequent home hemodialysis with the NxStage System One.
In-center dialysis treatment three days a week forced me to spend my free time sleeping, and missing precious moments of my life, said Laurie. When my kidneys failed for the second time, I switched to more frequent home hemodialysis treatment with NxStage and felt a difference within the first week. It gave me back the only thing that matters to me, time. Time with my husband.
During Laurie’s time on NxStage therapy, the couple established a social media presence and networked to reach thousands of people with her story. Together they found a donor, and Laurie is now recovering from her second transplant earlier this year. Learn more about Laurie and Mike in her video Laurie’s Story – A Message of Courage, Determination and Hope.
About the NxStage System One
The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients’ homes and give patients the freedom to travel with their therapy. When combined with the NxStage Pureflow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on demand. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs – at home or on vacation and at a medically appropriate treatment frequency. http://www.nxstage.com/.
About NxStage Medical
NxStage Medical Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company’s website at www.nxstage.com.
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words anticipate, believe, expect, estimate, plan, and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage’s filings with the Securities and Exchance Commission, including the Quarterly Report on Form 10-Q for the quarter ended September 30, 2013. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Kristen K. Sheppard, Esq., NxStage, VP, Investor Relations
SOURCE NxStage Medical, Inc.